4001 - 4050 of 9134 Results
Title
Year
- Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK22018OPENTitle: Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK2Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 19Issue #: 9Start Page: 2784End Page: 2784Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms19092784Best OA location URL: https://www.mdpi.com/1422-0067/19/9/2784/pdf?version=1537093660Citation Count: 2
-
OPENTitle: Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 12Start Page: e85443End Page: e85443Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0085443Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0085443&type=printableCitation Count: 18
-
OPENTitle: Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse ModelJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page: 981End Page: 981Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00981Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00981/pdfCitation Count: 60
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 100
- Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients2017RESTRICTEDTitle: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1423End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27136Citation Count: 176
-
OPENTitle: Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based MethodJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2095End Page: 2100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28175Citation Count: 33
- Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism2020OPENTitle: Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 72Issue #:Start Page: 75End Page: 79Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.02.003Best OA location URL: http://hdl.handle.net/11577/3350481Citation Count: 21
-
OPENTitle: Synapsin III is a key component of α‐synuclein fibrils in Lewy bodies of PD brainsJournal Name: Brain PathologyPublisher: WileyVol: 28Issue #: 6Start Page: 875End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bpa.12587Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8028549Citation Count: 51
-
OPENTitle: Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 16886End Page: 16886Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-73854-yBest OA location URL: https://www.nature.com/articles/s41598-020-73854-y.pdfCitation Count: 9
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page: 174End Page: 174Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 11
-
OPENTitle: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page: 100End Page: 100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00100Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00100/pdfCitation Count: 22
-
OPENTitle: Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synucleinJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1749Issue #:Start Page: 147131End Page: 147131Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2020.147131Best OA location URL: https://doi.org/10.1016/j.brainres.2020.147131Citation Count: 32
-
OPENTitle: Motor subtype changes in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 43Issue #:Start Page: 67End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.018Best OA location URL: http://doi.org/10.1016/j.parkreldis.2017.07.018Citation Count: 80
-
OPENTitle: Video-based Parkinson’s disease assessments in a nationwide cohort of Fox Insight participantsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 4Issue #:Start Page: 100094End Page: 100094Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100094Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100094Citation Count: 35
-
OPENTitle: The Interaction between HLA‐DRB1 and Smoking in Parkinson's Disease RevisitedJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1929End Page: 1937Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29133Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29133Citation Count: 14
- The HoloLens Augmented Reality System Provides Valid Measures of Gait Performance in Healthy Adults2020RESTRICTEDTitle: The HoloLens Augmented Reality System Provides Valid Measures of Gait Performance in Healthy AdultsJournal Name: IEEE Transactions on Human-Machine SystemsPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 50Issue #: 6Start Page: 584End Page: 592Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/thms.2020.3016082Citation Count: 21
-
OPENTitle: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 672End Page: 680Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28382Best OA location URL: https://doi.org/10.1002/mds.28382Citation Count: 23
- Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease2018RESTRICTEDTitle: Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 621End Page: 639Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1892-1Citation Count: 64
- Improved Neuroimaging Atlas of the Dentate Nucleus2017RESTRICTEDTitle: Improved Neuroimaging Atlas of the Dentate NucleusJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 16Issue #: 5-6Start Page: 951End Page: 956Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-017-0872-7Citation Count: 29
-
OPENTitle: Complementary Mitochondrial and α‐Synuclein Signatures Refine Biological Stratification of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70437Best OA location URL: https://doi.org/10.1002/mds.70437Citation Count: 0
- Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”2025RESTRICTEDTitle: Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 10Start Page: 2287End Page: 2288Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.70053Citation Count: 0
-
OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 115Issue #: 51Start Page: E12053End Page: E12062Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 92
- [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers2019OPENTitle: [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteersJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 46Issue #: 10Start Page: 2051End Page: 2064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-019-04369-6Citation Count: 83
- Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease2018RESTRICTEDTitle: Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's diseaseJournal Name: European Journal of Medical GeneticsPublisher: Elsevier BVVol: 62Issue #: 1Start Page: 65End Page: 69Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmg.2018.05.005Citation Count: 69
-
OPENTitle: TBK1 Induces the Formation of Optineurin Filaments That Condensate with Polyubiquitin and LC3 for Cargo SequestrationJournal Name: Advanced SciencePublisher: WileyVol: 13Issue #: 16Start Page: e09927End Page: e09927Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202509927Best OA location URL: https://doi.org/10.1002/advs.202509927Citation Count: 1
-
OPENTitle: Addressing the Challenges of Translating LRRK2 Biology into Disease‐Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange InitiativeJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70397Best OA location URL: https://doi.org/10.1002/mds.70397Citation Count: 0
-
OPENTitle: O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effectJournal Name: Physical BiologyPublisher: IOP PublishingVol: 18Issue #: 1Start Page: 016002End Page: 016002Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1478-3975/abb6dcBest OA location URL: https://iopscience.iop.org/article/10.1088/1478-3975/abb6dc/pdfCitation Count: 24
-
OPENTitle: Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic MiceJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 623End Page: 635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.omtn.2020.06.027Best OA location URL: http://www.cell.com/article/S2162253120301888/pdfCitation Count: 46
-
OPENTitle: Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 1Start Page: 165End Page: 176Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.25944Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25944Citation Count: 75
-
OPENTitle: A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein MiceJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 1Start Page: 74End Page: 90Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.25920Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25920Citation Count: 67
- Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease2016RESTRICTEDTitle: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 113Issue #:Start Page: 110End Page: 123Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028Citation Count: 64
- A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies2023OPENTitle: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studiesJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 85Issue #:Start Page: 59End Page: 67.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019Citation Count: 7
-
OPENTitle: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 288End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6386531Citation Count: 93
-
OPENTitle: TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 40Start Page: 10773End Page: 10778Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1713969114Best OA location URL: https://www.pnas.org/content/pnas/114/40/10773.full.pdfCitation Count: 133
-
OPENTitle: A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrilsJournal Name: MethodsPublisher: Elsevier BVVol: 252Issue #:Start Page: 41End Page: 54Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymeth.2026.05.001Best OA location URL: https://doi.org/10.1016/j.ymeth.2026.05.001Citation Count: 0
- Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression2020OPENTitle: Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1466End Page: 1471Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28073Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28073Citation Count: 32
- Parkinson's Progression Markers Initiative brain autopsy program2022RESTRICTEDTitle: Parkinson's Progression Markers Initiative brain autopsy programJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 62End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.017Citation Count: 10
-
OPENTitle: Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brainJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 16Issue #: 40Start Page: 18882End Page: 18898Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d4nr03002hBest OA location URL: http://dx.doi.org/10.1039/d4nr03002hCitation Count: 0
-
OPENTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 19
- Regional gray matter changes and age predict individual treatment response in Parkinson's disease2018OPENTitle: Regional gray matter changes and age predict individual treatment response in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 21Issue #:Start Page: 101636End Page: 101636Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.101636Best OA location URL: https://doi.org/10.1016/j.nicl.2018.101636Citation Count: 26
-
OPENTitle: Disruption of the LRRK2‐FADD Interface Using Constrained PeptidesJournal Name: Peptide SciencePublisher: WileyVol: 116Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/pep2.24374Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pep2.24374Citation Count: 3
-
OPENTitle: Dual threshold neural closed loop deep brain stimulation in Parkinson disease patientsJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 4Start Page: 868End Page: 876Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.02.020Best OA location URL: https://doaj.org/article/19f814aa99e84c419e9f19765cc1add3Citation Count: 268
- Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies2017RESTRICTEDTitle: Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathiesJournal Name: Clinica Chimica ActaPublisher: Elsevier BVVol: 466Issue #:Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cca.2017.01.010Citation Count: 30
-
OPENTitle: T-cell based immunotherapies for Parkinson’s diseaseJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol: 1Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2021.00007Best OA location URL: https://www.explorationpub.com/uploads/Article/A10047/10047.pdfCitation Count: 11
- No anti-IgLON5 antibody in carefully diagnosed PSP patients with “atypical” or variant clinical features2025RESTRICTEDTitle: No anti-IgLON5 antibody in carefully diagnosed PSP patients with “atypical” or variant clinical featuresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108071End Page: 108071Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108071Citation Count: 0
-
OPENTitle: Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s DiseaseJournal Name: eneuroPublisher: Society for NeuroscienceVol: 8Issue #: 4Start Page: ENEURO.0559End Page: 20.2021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0559-20.2021Best OA location URL: https://www.eneuro.org/content/eneuro/8/4/ENEURO.0559-20.2021.full.pdfCitation Count: 14
-
OPENTitle: Novel lower-extremity dexterity assessment for Parkinson’s disease: validation against measures of arm dexterity and general mobilityJournal Name: Disability and RehabilitationPublisher: Informa UK LimitedVol: 45Issue #: 2Start Page: 291End Page: 300Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/09638288.2021.2025273Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9428931Citation Count: 6
- Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA2016RESTRICTEDTitle: Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISAJournal Name: Analytical and Bioanalytical ChemistryPublisher: Springer Science and Business Media LLCVol: 408Issue #: 27Start Page: 7669End Page: 7677Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00216-016-9863-7Citation Count: 29
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 29
-
OPENTitle: The cross-linking activity of transglutaminase 2 drives α-Synuclein pathology in synucleinopathy modelsJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 123Issue #: 12Start Page: e2517886123End Page: e2517886123Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2517886123Best OA location URL: https://doi.org/10.1073/pnas.2517886123Citation Count: 0